Societies aim to open TAVR to more patients

02/14/2013 | Forbes · CardiovascularBusiness.com

The Society of Thoracic Surgeons and the American College of Cardiology have received investigational device exemption approval to conduct a clinical study evaluating broader use of transcatheter aortic valve replacement. This marks the first time medical societies have pursued an IDE, according to SCAI trustee Dr. Ralph Brindis. "The goal of the effort is to gain reimbursement for an expanded set of procedures with Sapien to make the device accessible to more patients," he said. The groups are now pursuing FDA approval for two more studies in hopes of expanding the uses of transcatheter aortic valve replacement.

View Full Article in:

Forbes · CardiovascularBusiness.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI